Survodutide
Survodutide is a dual GLP-1/glucagon receptor agonist studied for its potential metabolic effects and energy regulation.
What This Compound Is
Survodutide is a dual agonist that activates both GLP-1 and glucagon receptors. This peptide combines the metabolic benefits of both receptor systems. Researchers study Survodutide for its effects on glucose metabolism, energy expenditure, and body composition in laboratory settings.
Research Interest
Scientific research on Survodutide examines its dual receptor activation and metabolic effects. Studies focus on its influence on glucose homeostasis, energy expenditure, hepatic glucose production, and fat oxidation. Researchers investigate its mechanisms involving combined GLP-1 and glucagon receptor signaling, metabolic rate enhancement, and potential synergistic metabolic benefits in experimental models.
Educational Disclaimer
For laboratory research purposes only. Not for human consumption or clinical use. This product is intended solely for in-vitro research and educational applications.
Available Formats
Related Research Compounds
Explore similar peptides and compounds that researchers often study together